Swedish Orphan Biovitrum AB Non-GAAP EPS of SEK 2.36, revenue of SEK 6.17B; reaffirms FY25 outlook
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jul 16 2025
0mins
Source: SeekingAlpha
Q2 Financial Performance: Swedish Orphan Biovitrum AB reported a Q2 Non-GAAP EPS of SEK 2.36 and revenue of SEK 6.17 billion, reflecting a year-over-year increase of 13.4%.
Future Outlook: The company's outlook for 2025 remains unchanged, with expectations for revenue growth in the high single-digit percentage range at constant exchange rates and an adjusted EBITA margin projected to be in the mid-30s percentage of revenue.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
